Not a Portfolio.com Insider?

Subscribe and get a FREE gift!

In This Issue of Condé Nast Portfolio

Home > Resources > Company Profiles > CVS Caremark Corporation

CVS Caremark Corporation (CVS)

Your Name

Your Email Address *
Send a copy to me

Recipient's Email Address *

Separate multiple email addresses (max 20) with commas.

Subject *

Message

0/1500

Email Confirmation

Thomas M. Ryan , CEO/Director/President/Chairman of the Board

www.cvs.com

Industry: Retail

OPEN

LAST

PREV CLOSE

CHANGE

VOLUME

Overview

News

People

Financials

Overview

The Company is a provider of prescriptions and related healthcare services in the United States. It operates two business segments: Retail Pharmacy and Pharmacy Services.

Portfolio Articles

Valentine's Day: Outsource It
How to have your assistant choose a gift that says “I bought this myself.”

Feb 08 2008
For the YouTuber in You
Two low-priced, point-and-shoot video cameras designed to keep things simple.
Nov 19 2007

See more news on this company

News Feeds

Food and drug retail stocks a better buy in 2008 AP
Dec 31 2008
US-BUSINESS Summary Reuters
Dec 23 2008
Outlook roundup: AbitibiBowater, CVS Caremark AP
Dec 22 2008
CVS Caremark backs 2008 profit forecast AP
Dec 22 2008
Sector Snap: Drugstores waver after rate cut AP
Dec 16 2008
Analyst says insurers won't take much PBM business AP
Dec 16 2008

Portfolio Blogs

Ackman's Short Win on Longs
Aug 12 2008
The Redcoats Are Coming
Jul 18 2007

Press Releases

MinuteClinic Becomes Participating Provider With Blue Cross and Blue Shield of Florida Jan-07-2009, 08:29AM EST
Skinny Dippers(TM), First Zero-Calorie Frozen Dessert, Earns Widespread Retail, Online Distribution Jan-06-2009, 05:57PM EST
CVS/pharmacy Offers Shoppers More Than $69 Million in 'Extra Bucks' Jan-06-2009, 08:30AM EST
Research and Markets: CVS Corporation - Company PicShot Provides a Detailed View Jan-05-2009, 07:33AM EST
CVS Caremark Corporation to Present at the JPMorgan Health Care Conference on January 13th Jan-02-2009, 02:00PM EST

News From Around the Web

News

CVS Caremark 2009 Earnings Guidance Conference Call At 8:30 AM (RTTNews)

Jan 09 2009
Plans for building retail space, CVS in Hampton on hold (Seacoast Online, Maine; New Hampshire)

Jan 09 2009
» Shoplifting suspects yield cache of drugs (Worcester Telegram & Gazette)

Jan 09 2009
CVS foreseen in Cary (News & Observer, North Carolina)

Jan 09 2009
CVS Caremark's Privacy Practices, Conflicts of Interest Subject of D.C. City Council Hearing (Investors Business Daily)

Jan 08 2009
Longs Drugstore to close Monday (Orange County Register)

Jan 08 2009
Micozzi Pays $7.2M for CVS Retail Site (CoStar - Boston)

Jan 08 2009
CVS Caremark Corporation to Hold 2009 Earnings Guidance Conference Call (StreetInsider)

Jan 08 2009
Hingham residents: No CVS in my neighborhood (Patriot Ledger, Quincy, MA)

Jan 08 2009
Mount Vernon CVS hearing draws tiny turnout (Journal News)

Jan 08 2009

Employees

Number of Employees: 120,000

Revenue per Employee: $692,181

Financials

Quarterly

Annual

Income Statement	10/2008	08/2008	05/2008	02/2008
Sales	16.15 Bil.	16.46 Bil.	16.73 Bil.	17.21 Bil.
Gross Operating Profit	4.71 Bil.	4.68 Bil.	4.59 Bil.	4.73 Bil.
Operating Income before D & A (EBITDA)	1.78 Bil.	1.79 Bil.	1.67 Bil.	1.75 Bil.
Total Income Before Interest Expenses (EBIT)	1.47 Bil.	1.48 Bil.	1.38 Bil.	1.48 Bil.
Total Net Income	736 Mil.	774.8 Mil.	748.5 Mil.	815 Mil.
Basic EPS, Total	0.51	0.54	0.52	0.56
Diluted EPS, Total	0.5	0.53	0.51	0.55

BALANCE STATEMENT	10/2008	08/2008	05/2008	02/2008
Cash and Equivalents	1.28 Bil.	615.7 Mil.	818.2 Mil.	1.06 Bil.
Total Assets	14.97 Bil.	13.61 Bil.	13.91 Bil.	14.1 Bil.
Total Liabilities	9.88 Bil.	8.81 Bil.	9.78 Bil.	10.77 Bil.
Total Capitalization	41.78 Bil.	41.36 Bil.	40.5 Bil.	39.67 Bil.

Cash Flow	10/2008	08/2008	05/2008	02/2008
Net Cash From Continuing Operations	2.18 Bil.	1.39 Bil.	740.8 Mil.	3.23 Bil.
Net Cash From Investing Activities	-1.27 Bil.	-862.7 Mil.	-346.8 Mil.	-3.08 Bil.
Net Cash From Financing Activities	-679.5 Mil.	-970.3 Mil.	-632.4 Mil.	377.9 Mil.
Net Change in Cash & Cash Equivalents	225.7 Mil.	-440.9 Mil.	-238.4 Mil.	525.9 Mil.

Income Statement	2008	2007	2006	2005
Sales	59.12 Bil.	31.87 Bil.	27.1 Bil.	22.62 Bil.
Gross Operating Profit	17.2 Bil.	11.94 Bil.	9.9 Bil.	7.97 Bil.
Operating Income before D & A (EBITDA)	5.89 Bil.	3.17 Bil.	2.61 Bil.	1.89 Bil.
Total Income Before Interest Expenses (EBIT)	4.79 Bil.	2.46 Bil.	2.03 Bil.	1.45 Bil.
Total Net Income	2.64 Bil.	1.37 Bil.	1.22 Bil.	918.8 Mil.
Basic EPS, Total	1.97	1.65	1.49	1.14
Diluted EPS, Total	1.92	1.6	1.45	1.1

BALANCE STATEMENT	2008	2007	2006	2005
Cash and Equivalents	1.06 Bil.	530.7 Mil.	513.4 Mil.	392.3 Mil.
Total Assets	14.1 Bil.	10.39 Bil.	8.39 Bil.	7.92 Bil.
Total Liabilities	10.77 Bil.	7 Bil.	4.58 Bil.	4.86 Bil.
Total Capitalization	39.67 Bil.	12.79 Bil.	9.93 Bil.	8.91 Bil.

Cash Flow	2008	2007	2006	2005
Net Cash From Continuing Operations	3.23 Bil.	1.74 Bil.	1.61 Bil.	914.2 Mil.
Net Cash From Investing Activities	-3.08 Bil.	-4.59 Bil.	-911.6 Mil.	-3.16 Bil.
Net Cash From Financing Activities	377.9 Mil.	2.87 Bil.	-579.4 Mil.	1.8 Bil.
Net Change in Cash & Cash Equivalents	525.9 Mil.	17.3 Mil.	121.1 Mil.	-450.9 Mil.